Shropshire Thomas B Jr. 4

What Happened Thomas B. Shropshire Jr., Senior Vice President and General Counsel of Thermo Fisher Scientific (TMO), received equity awards on February 25, 2026. The filing reports two award items: 978 shares acquired at $0.00 and 4,281 derivative award units acquired at $0.00 (totaling 5,259 shares/units). These were grants (code A) rather than open-market purchases or sales.

Key Details

• Transaction date: 2026-02-25; Filing date: 2026-02-27 (timely filing).
• Award amounts: 978 shares (non-derivative) and 4,281 derivative units; reported price per share/unit: $0.00.
• Shares owned after the transaction: Not disclosed in this filing.
• Footnote: The derivative award vests in four equal annual installments beginning February 28, 2027 (F1).
• Transaction type: Compensation grant (award), not a cash purchase or sale.

Context

• These entries reflect equity compensation — a typical form of executive pay — and do not indicate an open-market purchase or immediate sale. The derivative award vests over four years, meaning the economic interest is subject to future vesting conditions rather than immediate, unrestricted ownership.